Merck seeks first U.S. authorization for COVID-19 pill
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- Wall St falls as bond yields test multi-decade highs
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Stocks fall as higher oil prices, Treasury yields weigh
- Oppenheimer sees AI software winners as focus shifts to ROI
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
EU may consider deal on Merck's (MRK) COVID pill after approval procedure begins - source - Reuters
October 12, 2021 10:39 AM EDTEU may consider deal on Merck's (NYSE: MRK) COVID pill after approval procedure begins - source - Reuters
... MoreUPDATE: Merck (MRK) Commences Cash Tender Offer to Acquire Acceleron Pharma (XLRN) for $180/sh, Deal Announced on Sept. 30
October 12, 2021 6:47 AM EDT(Updated - October 12, 2021 6:51 AM EDT)
Merck (NYSE: MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Acceleron Pharma Inc. (Nasdaq: XLRN). On Sept. 30, 2021, Merck announced that it had entered into a... More
